文献速递心脏核医学

成纤维细胞激活蛋白显像用于心房颤动:一项概念验证研究

Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
PubMed 文献 · J Nucl Cardiol · 2023-08-25

该概念验证研究在5只左心耳起搏比格犬心房颤动模型及28例心房颤动患者与10名年龄性别匹配健康志愿者中行18F-FAPI PET/CT显像,评估心房活化成纤维细胞。犬模型右心房18F-FAPI摄取增高,28例患者中18例(64.3%)心房FAPI活性增强,健康志愿者及假手术犬未见心房摄取。

要点

  • 比格犬左心耳起搏8周后右心房18F-FAPI摄取增高,假手术犬未见心房摄取。
  • 28例心房颤动患者中18例(64.3%)心房18F-FAPI活性增强,健康志愿者均未见心房摄取。
  • 动物右心房标本18F-FAPI活性与FAP mRNA(r=.98,P=.002)、FAP蛋白(r=.82,P=.03)及I型胶原mRNA(r=.85,P=.02)正相关。

核心结论

  • 这项概念验证研究提示,18F-FAPI PET/CT显像可能是评估心房颤动患者心房活化成纤维细胞的一种可行方法。

研究设计与样本

  • 构建5只左心耳起搏比格犬心房颤动模型,于基线和起搏后8周行18F-FAPI PET/CT显像并采集右心房标本。
  • 28例心房颤动患者与10名年龄和性别匹配的健康志愿者接受18F-FAPI PET/CT显像。

主要发现

  • 心房颤动比格犬右心房18F-FAPI摄取增高,假手术比格犬未见心房18F-FAPI摄取。
  • 28例心房颤动患者中18例(64.3%)心房FAPI活性增强,健康志愿者未见心房18F-FAPI摄取。
  • 动物右心房标本中18F-FAPI活性与FAP mRNA(r=.98,P=.002)、FAP蛋白(r=.82,P=.03)及I型胶原mRNA(r=.85,P=.02)呈正相关。
  • B型利钠肽水平与心房18F-FAPI活性相关(OR=3.01,P=.046)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate the feasibility of using radiolabeled fibroblast activation protein inhibitor (FAPI) PET/CT imaging to assess activated fibroblasts in the atria of individuals with AF and to identify factors contributing to enhanced atrial activity. METHODS: We constructed left atrial appendage (LAA) pacing beagle dog AF models (n = 5) and conducted 18F-FAPI PET/CT imaging at baseline and eight weeks after pacing. Right atrial (RA) specimens were collected from these models. Additionally, 28 AF patients and ten age- and sex-matched healthy volunteers underwent 18F-FAPI PET/CT imaging. RESULTS: RA of AF beagles showed increased 18F-FAPI uptake. Among AF patients, 18 out of 28 (64.3%) exhibited enhanced atrial FAPI activity. No atrial 18F-FAPI uptake was observed in the sham beagle and healthy volunteers. In animal RA specimens, 18F-FAPI activity correlated positively with FAP mRNA (r = .98, P = .002) and protein (r = .82, P = .03) levels, as well as collagen I mRNA expression (r = .85, P = .02). B-type natriuretic peptide levels were associated with atrial 18F-FAPI activity (OR = 3.01, P = .046). CONCLUSION: This proof-of-concept study suggests that 18F-FAPI PET/CT imaging may be a feasible method for evaluating activated fibroblasts in the atria of AF patients.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Li L, Gao J, Chen BX, et al. Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study. J Nucl Cardiol. 2023. PMID: 37626209. doi:10.1007/s12350-023-03352-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。